News & Articles

The authorization enables emergency use of Actemra/RoActemra for the treatment of COVID-19 in hospitalized adult and pediatric patients

LGC has been working with NHS Test and Trace to support the UK's response to the pandemic

VITROS Anti-SARS-CoV-2 IgG Quantitative Test targets the S1 spike protein and is calibrated to the WHO International Standard for anti-SARS-CoV-2 IgG antibodies

Top talks and new resources detailing key developments in the fields of clinical research and diagnostics are now available on demand

Univercells Technologies will work with VectorBuilder to develop and optimize NevoLine Upstream platform and scale-X bioreactors for the production of custom viral vectors

The new media panel, gene kit and advanced resins help reduce manufacturing costs while increasing the viability of gene therapies

Watch exclusive interviews with leading industry experts on the importance of precision cold storage equipment

The clinical data for Avacta’s AffiDX SARS-CoV-2 antigen lateral flow test demonstrated 100% sensitivity

The facility will be capable of manufacturing batches ranging from those for early-stage research to GMP for clinical and future commercial uses

Scientific, technological and communications excellence has been celebrated at the Clinical Science Summit, with Beckman Coulter, Zymo Research, and PerkinElmer among those recognized

Learn about the large scale COVID-19 PCR testing program set up by the government of Luxembourg

Updated version of highly sensitive and accurate COVID-19 PCR kit accounts for known and future viral mutations

Solutions combine liquid-based sample preparation with PCR detection and Sanger sequencing

Dr. Vikramsingh Gujar, from Northwestern University, discusses his research on inflammatory disorders and why effective knowledge share is vital for scientific advancement

Consortium formed to lower costs of cell and gene therapies through process development and manufacturing collaborations

Top talks presenting the latest technologies, research and applications are now available on demand

Novel chip-based diagnostic technology can detect individual viral antigens in nasal swab samples to identify the viruses that cause COVID-19 and flu with a single test